Stay updated with breaking news from Application Notes. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
The stakes are high in biologics development, especially in host cell protein (HCP) analysis. Get it wrong and it could delay your development cycle. See how optimizing your HCP assays can smooth your route to market.
27 January 2021 Circulating tumor cells (CTC) are rare cells shed from a solid tumor or metastases that circulate through the bloodstream. Detection of CTC poses a challenge because they are present at extremely low concentrations, as few as a couple CTC in several milliliters of blood, which contain up to 3 to 6 million cells per mL. To determine the sensitivity and accuracy of rare cell detection on the Agilent NovoCyte Quanteon flow cytometer, a tumor cell spiking assay was used in which a small number of cells from a tumor cell line was added to whole blood and detected by a cell surface ...
Philips TV Tuner History pt5 Competition and Growth Introduction We have reached the end of the 1980s, probably the turning point in the Philips Tuner history. On the one hand the business has been doing well: constant consolidation of (mainly European and US) competitors has substantially increased the market share and volumes, making it one of the global top3 tuner makers. However, in parallel the emergence of Japanese competition has made the business environment increasingly harsh, with a serious pressure on profitability and thus cost. Although Philips with its UV800 tuner family has pro...
The global epidemic caused by SARS-CoV-2 virus has raised a need for serological testing to detect SARS-CoV-2 specific antibodies. Serological testing can be used as a convenient tool e.g. in epidemiological studies to understand and monitor the progression of epidemic in populations. For the vaccine development serological testing can be used in clinical trials to monitor vaccine response and IgG formation over time. After vaccination programs have been implemented, serological sur
at pre-award status and no decision has been made on the claim as a result of an operator error - for example, the same claim has been captured twice or when at post-award status and no award or payments have been made for the following tax year (CY+1). A request can be made to prevent an award being made in the following tax year (CY+1), but the current year (CY) must continue. Note: The claim cannot be withdrawn once a decision has been made and it has been awarded. Note: For tax year 2010-2011 Nil Award cases were automatically withdrawn and customers had until 17 May 2011 (this is known a...